Expression and Identification of N-acetylglucosamine-6-sulfatase (GNS): A Potential ERT Drug for Sanfilippo Syndrome D
CSEF · 2013 Biochemistry/ Molecular Biology
Overview
Objectives/Goals There is currently no cure for Mucopolysaccharidosis IIID (MPS IIID or Sanfilippo syndrome D), which is a genetic lysosomal storage disorder caused by an absent lysosomal enzyme, N-acetyl-glucosamine-6-sulfatase (GNS). However, an enzyme replacement therapy (ERT) treatment may be a potential way to attenuate symptoms for MPS IIID patients. In order to obtain enough enzyme for the ERT, I isolated the highest GNS expressing Chinese hamster ovary (CHO) cells transfected with the human GNS gene. Methods/Materials The human GNS gene was transfected into Chinese hamster ovary (CHO) cell lines, and the protein was purified from the culture medium. A sulfatase activity assay was used to isolate the highest expressing clones out of 58 original clones, after which, the GNS fluorescent intensity assay was run to confirm the expression of these clones. After the highest expressers were isolated, they were re-cultured and their activities were monitored over two weeks. Then, two cell lines of MPS IIID fibroblasts were incubated with the CHO cell culture medium and tested for GNS uptake. Results Nine clones showed the highest sulfatase activity, and when monitored over two weeks, their activities all increased. After the screening with the GNS fluorescent intensity assay, however, these clones showed lower GNS activities than expected, suggesting that another CHO cell line needs to be transfected with the human GNS gene to acquire greater expression of the enzyme. After the fibroblasts were incubated with the CHO culture medium, the sulfatase activity inside the fibroblast cells was similar to that in the original clone culture medium. Conclusions/Discussion Although the ideal amount of GNS was not secreted by the transfected CHO cells, the optimization of the GNS assay and confirmation of a functioning GNS pure protein were achieved. Because the sulfatase activity following the uptake assay was similar to that of the original clones# culture mediums, it suggested that the cells contained similar amounts before and after the incubation. In the future, the GNS produced by the transfected CHO cells may be used in ERT to treat patients with Sanfilippo Syndrome D.
Summary statement
I isolated the highest GNS expressing Chinese hamster ovary (CHO) cells transfected with the human GNS gene in order to obtain enough enzyme for future ERT treatments.
Help received
Used Los Angeles Biomedical Research Institute facilities under the supervision of Dr. Patricia Dickson
Competition history
- CSEF 2013
Resources
Related projects
CSEF · 2008
Construction of an IGF-NAGLU Fusion Protein for Treatment of Sanfilippo B Syndrome
CSEF · 2010
In vitro Analysis of a Synthetic Protein: A Model for Enzyme Replacement Therapy
CSEF · 2019
Generation of MPS IIIA Induced Pluripotent Stem Cells for Correction Using CRISPR Cas9
CSEF · 2015
Pathology and Chemistry of the Brain in Sanfilippo Syndrome Type B
CYSF · 2026
Investigating lysosomal storage disease mucopolysaccharidosis(III) and viral vector gene therapy treatments
CSEF · 2017
Hormonal Regulation of Hexosaminidase: Implications for Tay-Sachs Disease
ISEF · 2019
What Is the Efficacy of Iminosugars in Inhibiting Glucosylceramide Synthase in Canine Macrophages?
ISEF · 2015
Pathology and Chemistry of the Brain in Sanfilippo Syndrome Type B
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects